Cannapharmarx, Inc. financial data

Symbol
CPMD on OTC
Industry
Pharmaceutical Preparations
Location
Suite 3600, 888 3 Rd Street Sw, Calgary, Alberta, Canada
State of incorporation
DE
Fiscal year end
December 31
Former names
GOLDEN DRAGON HOLDING CO. (to 10/27/2014), CCVG, INC. (to 1/12/2011), CONCORD VENTURES, INC. (to 11/17/2010), CAVION TECHNOLOGIES INC (to 7/25/2007)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.68 % +412%
Debt-to-equity -144 % -7.8%
Return On Equity 39.3 % -54.3%
Return On Assets -142 % +50.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 663M shares +120%
Common Stock, Shares, Outstanding 663M shares +125%
Entity Public Float 2.61M USD -26.4%
Common Stock, Value, Issued 66.3K USD +125%
Weighted Average Number of Shares Outstanding, Basic 351M shares +19.7%
Weighted Average Number of Shares Outstanding, Diluted 663M shares +125%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 312K USD
General and Administrative Expense 51.2K USD -84.8%
Operating Income (Loss) -498K USD +25.4%
Nonoperating Income (Expense) 686K USD +566%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.24M USD +31%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 188K USD
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7K USD
Accounts Receivable, after Allowance for Credit Loss, Current 14.1K USD
Inventory, Net 1.22M USD
Other Assets, Current 0 USD -100%
Assets, Current 1.5M USD +2657%
Property, Plant and Equipment, Net 154K USD -8.03%
Operating Lease, Right-of-Use Asset 5.51M USD
Assets 11.7M USD +127%
Accounts Payable, Current 8.95M USD +15.2%
Liabilities, Current 22.5M USD +11.2%
Liabilities 28.3M USD +9.62%
Accumulated Other Comprehensive Income (Loss), Net of Tax 39.9K USD -61.9%
Retained Earnings (Accumulated Deficit) -97.4M USD +1.13%
Stockholders' Equity Attributable to Parent -16.6M USD +19.6%
Liabilities and Equity 11.7M USD +127%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -549K USD +10.3%
Net Cash Provided by (Used in) Financing Activities 560K USD +13.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 663M shares +125%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.4K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 5.85M USD
Depreciation 0 USD -100%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 84K USD
Property, Plant and Equipment, Gross 225K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.04M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 495K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.15M USD
Additional Paid in Capital 80.1M USD +6.48%
Depreciation, Depletion and Amortization 23K USD +295%
Interest Expense 632K USD +78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares